Prolonged, excessive exposure to fluoride can cause a debilitating bone disease known as skeletal fluorosis. The disease develops insidiously and can be difficult to distinguish from a number of other bone and joint diseases. Research shows that individual susceptibility to fluorosis varies greatly across the population, both with respect to the doses and duration of exposure that can cause the disease, and the skeletal manifestations and symptoms that result. Although skeletal fluorosis used to be considered a non-issue in the United States and other western countries, recent research suggests that many people — particularly heavy tea drinkers and those with kidney impairment — may unknowingly be suffering from some form of the disease.
Skeletal Fluorosis: A “Diagnostic Riddle”
One of the reasons doctors fail to detect skeletal fluorosis is because the symptoms and appearance of fluorosis can closely resemble other, more commonly known, bone and joint diseases. This is true for both the early and late stages of the disease.
In the initial stages, known as “pre-skeletal” fluorosis, a patient may suffer a variety of symptoms in the absence of any detectable bone changes, including joint pains, joint stiffness, and gastric distress. (Czerwinski 1988; Cook 1971). The absence of bone changes makes this pre-skeletal phase difficult to diagnose, because the symptoms are indistinguishable from common forms of arthritis, such as osteoarthritis and rheumatoid arthritis.
Even when bone changes do develop, correct diagnosis can remain elusive. This is because the bone changes in skeletal fluorosis mimic the bone changes in other diseases, including osteoarthritis, renal osteodystrophy, spondylosis, DISH, Paget’s Disease, and osteopetrosis. In 2011, for example, a team of U.S. scientists reported that a Georgia woman with crippling skeletal fluorosis, as evident by her severe hunchback (“kyphosis”), had to wait up to 18 years before doctors were able to diagnosis her condition as being caused by fluoride. (Whyte 2011). Other U.S. studies have reported similar results. Since doctors have difficulty diagnosing even the crippling stages of fluorosis, it is likely that earlier, subtler forms of the disease will often elude detection.
For over 40 years, U.S. health authorities insisted that skeletal fluorosis can not develop unless a person ingests 20 milligrams of fluoride per day for over 10 years. U.S. health authorities now concede, however, that skeletal fluorosis can occur at doses as low as 10 mg/day. (NRC 1993; Whitford 1996; IOM 1997; ATSDR 2003). This revised estimate, however, is itself outdated, as recent research has found that doses as low as 6 mg/day can cause early stages of the disease.
Another error underlying U.S. safety standards is the notion that skeletal fluorosis does not occur at water fluoride levels below 8 ppm. (IOM 1997; EPA 1985). Studies in India and China have repeatedly documented skeletal fluorosis at levels as low as 0.7 to 1.5 ppm fluoride. Even studies in the United States — despite being very small in scope — have reported advanced skeletal fluorosis in kidney patients at 1.7 ppm, (Johnson 1979) and crippling skeletal fluorosis at just 2.2 to 3.5 ppm. (Sauerbrunn 1965).
Individual susceptibility to fluorosis varies greatly across the population
The claim that skeletal fluorosis cannot occur if an individual consumes less than 10 mg/day of fluoride obscures the individual variability, and complexity, of fluorosis. As with any other toxic substance, individual susceptibility to fluoride varies considerably across the population. Research has documented, for example, that:
- some individuals can develop skeletal fluorosis despite having “safe” levels of fluoride in their bones and without any known excessive exposure to fluoride; (Sandberg 1985)
- individuals receiving the same dose of fluoride can exhibit dramatically different bone responses; (Chachra 2010)
- individuals with pre-skeletal fluorosis can suffer excruciating pain, while individuals with advanced fluorosis can remain symptom-free; (Franke 1975)
- although U.S. health authorities claim that fluorosis only develops after 10 or more years of exposure, children can develop the disease in as little as 6 months, (Teotia 1998), and some adults have developed it in as little as 2 to 7 years (Gerser 1983; Fratzl 1995; Felsenfeld 1991).
Skeletal fluorosis looks different in different individuals
Skeletal fluorosis is a far more complex disease than is generally perceived. This fact is highlighted by the very different forms the disease can take based on an individual’s nutritional status, health status, age, genetics, and exposure to aluminum. Whereas the dominant feature of skeletal fluorosis is generally considered to be hyper-dense bone in the spine (axial osteosclerosis), research has documented that:
- some fluorosis victims can suffer primarily from osteoarthritis without noticeable osteosclerosis in the spine,
- other fluorosis victims can suffer primarily from osteomalacia, osteoporosis, and/or secondary hyperparathyroidism without prominent osteosclerosis.
To the extent that doctors rely on osteosclerosis in the spine as the telltale marker of fluorosis, victims will continue to fall through the cracks.
Common Causes of Fluorosis
- Fluoridated Water for Kidney Patients
- Excessive Tea Consumption
- High-Fluoride Well Water (more likely to be a factor among deep wells)
- Industrial Fluoride Exposure
- Fluorinated Pharmaceuticals (Voriconazole & Niflumic Acid)
- Indoor coal burning (a common practice in China).
Fluorosis Bends Rural Gujurat at the Knees
Joint pain? It could be fluorosis
The next time you suffer from a persistent backache or an irritating stiff joint, don't attribute it to long hours spent at the computer. It could well be the result of fluorosis, a disease thought to affect people in rural India with no access to safe drinking water.
Fluoride, Arthritis, and the Specter of Misdiagnosed Skeletal Fluorosis in the US
It has been known since the 1930s that ingesting too much fluoride can cause stiff and painful joints. According to scientists who have studied this condition (commonly referred to as skeletal fluorosis), the joint damage caused by fluoride may mimic other, more common, forms of “arthritis,” making it easy to
Skeletal Fluorosis in India & its Relevance to the West
While the elevated consumption of water in warm climates such as India along with the increased incidence of malnutrition make direct comparisons of the Indian experience to the "West" difficult, it is striking to observe how narrow the margin is between the doses which cause advanced fluorosis in India and the doses that people are now regularly receiving in fluoridated communities.
Similarities between Skeletal Fluorosis and Renal Osteodystrophy
It is quite possible, and indeed likely, that some kidney patients diagnosed with renal osteodystrophy are either suffering from skeletal fluorosis or their condition is being complicated/exacerbated by fluoride exposure.
Kidney Patients Are at Increased Risk of Fluoride Poisoning
It is well established that individuals with kidney disease are susceptible to suffering bone damage and other ill effects from low levels of fluoride exposure. Kidney patients are at elevated risk because when kidneys are damaged they are unable to efficiently excrete fluoride from the body. As a result, kidney patients
Fluoridation, Dialysis & Osteomalacia
In the 1960s and 1970s, doctors discovered that patients receiving kidney dialysis were accumulating very high levels of fluoride in their bones and blood, and that this exposure was associated with severe forms of osteomalacia, a bone-softening disease that leads to weak bones and often excruciating bone pain. Based on
The 'Altered Recommendations' of the 1983 Surgeon General's Panel
"We believe that EPA staff and managers should be called to testify, along with members of the 1983 Surgeon Generals panel and officials of the Department of Human Services, to explain how the original recommendations of the Surgeon Generals panel were altered to allow EPA to set otherwise unjustifiable drinking water standards for fluoride."
Fluoride & the Brain: An Interview with Dr. Phyllis Mullenix
The following interview with Phyllis Mullenix took place on October 18, 1997. The interviewer is Paul Connett. I. ACADEMIC BACKGROUND Connett: We're talking with Dr. Phyllis Mullenix, who in 1995, published a very important work on the neurotoxic effects of fluoride in rat studies. And Phyllis would you begin by telling us your
Interview with EPA's Dr. William Hirzy About Fluoride & Cancer
The following is an excerpt of Michael Connett's interview with Dr. J. William Hirzy, Senior Vice President of EPA's Headquarters Union in Washington DC. The interview took place on July 3, 2000, a couple days after Hirzy testified before the US Senate calling for an independent review of the tumor slides from
Related Miscellaneous Content: